At a glance
ClinicalIndex Comparison RecordN/ACompleted· 51 enrolled
Drug / intervention
CopiOs Pericardium Membranedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Prospective, Multi-Center Study of CopiOs® Pericardium Membrane With Puros® Cancellous Particulate Allograft for Localized Alveolar Ridge Augmentation
In Brief
A clinical study evaluating CopiOs Pericardium Membrane for Alveolar Ridge Defect. Completed, enrolled 51 participants across 4 sites.
Detailed Summary
This is a prospective, multi-center study to evaluate the use of CopiOs Pericardium Membrane, a bovine xenograft, with use of Puros Cancellous Particulate Allograft, for the augmentation of localized alveolar ridge defects on either the maxilla or mandible.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAlveolar Ridge Defect
CountriesUnited States
CollaboratorsZimmer Dental
Timeline
N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedApr 2009
Enrollment StartJun 2009
Primary CompletionDec 2011
TodayJul 2026
First PostedApr 28, 2009
Enrollment StartJun 1, 2009
Primary CompletionDec 1, 2011
TodayJul 2, 2026
Enrollment to primary: 2.5 yearsPosted 17.2 years ago
Interventions
CopiOs Pericardium Membranedevice
CopiOs Pericardium, Puros Cancellous